Get a glimpse into our company and investor data—powered by the PitchBook Platform
Synthon (rights of glatiramer acetate)
Asset Purch.LATEST DEAL TYPE
The commercialization rights of glatiramer acetate in the United States. It is a potential generic version of the originator medicine Copaxone® for the treatment of relapsing remitting multiple sclerosis (RRMS).